VTCN1 Anticorps
(V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1))
Choisissez l’un des 174 anticorps VTCN1 de notre liste de produits basés sur 2 publications et 63 images de validation.
Découvrez des anticorps VTCN1 fiables issus d’une large sélection de fabricants renommés. Notre portefeuille permet une détection précise de VTCN1 dans plusieurs espèces, y compris Human, Rat, Mouse, Cow, Dog, Guinea Pig, Horse, Rabbit, et prend en charge diverses applications de recherche telles que WB, FACS, IHC, ELISA, IF.
Trouvez rapidement l’anticorps adapté grâce à nos outils de recherche, de filtrage et de comparaison. Chaque page produit fournit des données de validation détaillées, des références bibliographiques et des retours d’utilisateurs. Contrairement aux ressources dédiées uniquement à la comparaison, vous pouvez acheter directement les anticorps sur notre site. Choisissez parmi des anticorps polyclonaux, monoclonaux ou recombinants VTCN1, issus de différents hôtes tels que Rabbit, Mouse, Human. Parcourez nos produits ci-dessous et commandez directement pour soutenir vos recherches en toute confiance.
Les noms alternatifs de VTCN1 sont vtcn1.L, VTCN1, vtcn1, Vtcn1.
| Catalog no. | Produit | Reactivité | Hôte / Clonalité | Application | Prix et délai de livraison |
|---|---|---|---|---|---|
| VTCN1 anticorps (CF®488A) | Humain | Souris Monoclonal |
|
306,46 €
Voir le prix
|
|
| VTCN1 anticorps | Humain | Souris Monoclonal |
|
348,31 €
Voir le prix
|
|
| VTCN1 anticorps (CF®594) | Humain | Souris Monoclonal |
|
306,46 €
Voir le prix
|
|
| VTCN1 anticorps (Biotin) | Humain | Souris Monoclonal |
|
306,46 €
Voir le prix
|
|
| VTCN1 anticorps (CF®640R) | Humain | Souris Monoclonal |
|
306,46 €
Voir le prix
|
|
| VTCN1 anticorps (CF®405S) | Humain | Souris Monoclonal |
|
306,46 €
Voir le prix
|
|
| VTCN1 anticorps (CF®647) | Humain | Souris Monoclonal |
|
306,46 €
Voir le prix
|
|
| VTCN1 anticorps (CF®740) | Humain | Souris Monoclonal |
|
313,85 €
Voir le prix
|
|
| VTCN1 anticorps (CF®568) | Humain | Souris Monoclonal |
|
306,46 €
Voir le prix
|
|
| Recombinant VTCN1 anticorps (Internal Region) | Humain | Lapin Monoclonal |
|
523,52 €
Voir le prix
|
|
| VTCN1 anticorps (AA 25-259) | Humain | Lapin Polyclonal |
|
435,12 €
Voir le prix
|
|
| VTCN1 anticorps (PerCP) | Humain | Human Monoclonal |
|
363,00 €
Voir le prix
|
|
| VTCN1 anticorps (FITC) | Humain | Souris Monoclonal |
|
363,00 €
Voir le prix
|
|
| VTCN1 anticorps (PE) | Humain | Human Monoclonal |
|
363,00 €
Voir le prix
|
|
| VTCN1 anticorps (FITC) | Humain | Human Monoclonal |
|
363,00 €
Voir le prix
|
|
| VTCN1 anticorps (APC) | Humain | Human Monoclonal |
|
363,00 €
Voir le prix
|
|
| VTCN1 anticorps | Humain | Human Monoclonal |
|
363,00 €
Voir le prix
|
|
| Recombinant VTCN1 anticorps | Humain | Human Monoclonal |
|
363,00 €
Voir le prix
|
|
| Recombinant VTCN1 anticorps | Humain | Human Monoclonal |
|
363,00 €
Voir le prix
|
|
| VTCN1 anticorps | Humain | Souris Monoclonal |
|
426,80 €
Voir le prix
|
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- VISTA-3007
- Conjugué
- CF®488A
- Isotype
- IgG2b, kappa
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- VISTA-3007
- Conjugué
- unconjugated
- Isotype
- IgG2b, kappa
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- VISTA-3007
- Conjugué
- CF®594
- Isotype
- IgG2b, kappa
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- VISTA-3007
- Conjugué
- Biotin
- Isotype
- IgG2b, kappa
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- VISTA-3007
- Conjugué
- CF®640R
- Isotype
- IgG2b, kappa
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- VISTA-3007
- Conjugué
- CF®405S
- Isotype
- IgG2b, kappa
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- VISTA-3007
- Conjugué
- CF®647
- Isotype
- IgG2b, kappa
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- VISTA-3007
- Conjugué
- CF®740
- Isotype
- IgG2b, kappa
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- VISTA-3007
- Conjugué
- CF®568
- Isotype
- IgG2b, kappa
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Monoclonal
- Clone
- RM525
- Conjugué
- unconjugated
- Type Proteine
- Recombinant Antibody
- Isotype
- IgG
- Epitope
- Internal Region
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- ICC (Immunocytochemistry: Application indiquée)
- IP (Immunoprecipitation: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Epitope
- AA 25-259
Primary Antibody
- Reactivité
- Humain
- Hôte
- Human
- Clonalité
- Monoclonal
- Clone
- ABS0181
- Conjugué
- PerCP
- Isotype
- IgG1, kappa
Primary Antibody
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- 7C8
- Conjugué
- FITC
- Isotype
- IgG2a, kappa
Primary Antibody
- Reactivité
- Humain
- Hôte
- Human
- Clonalité
- Monoclonal
- Clone
- ABS0181
- Conjugué
- PE
- Isotype
- IgG1, kappa
Primary Antibody
- Reactivité
- Humain
- Hôte
- Human
- Clonalité
- Monoclonal
- Clone
- ABS0181
- Conjugué
- FITC
- Isotype
- IgG1, kappa
Primary Antibody
- Reactivité
- Humain
- Hôte
- Human
- Clonalité
- Monoclonal
- Clone
- ABS0181
- Conjugué
- APC
- Isotype
- IgG1, kappa
Primary Antibody
- Reactivité
- Humain
- Hôte
- Human
- Clonalité
- Monoclonal
- Conjugué
- unconjugated
- Isotype
- IgG1, kappa
Primary Antibody
- Reactivité
- Humain
- Hôte
- Human
- Clonalité
- Monoclonal
- Clone
- NC762
- Conjugué
- unconjugated
- Type Proteine
- Recombinant Antibody
- Isotype
- IgG1, kappa
Primary Antibody
- Reactivité
- Humain
- Hôte
- Human
- Clonalité
- Monoclonal
- Clone
- AZD8205
- Conjugué
- unconjugated
- Type Proteine
- Recombinant Antibody
- Isotype
- IgG
Primary Antibody
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- 7C8
- Conjugué
- unconjugated
- Isotype
- IgG2a, kappa
Dernières publications pour nos VTCN1 Anticorps
: "The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma." dans: Journal of cancer research and clinical oncology, (2022) (PubMed).
: "Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 23, Issue 12, pp. 2934-2941, (2018) (PubMed).
: "Clinical relevance of expression of B7-H1 and B7-H4 in ovarian cancer." dans: Oncology letters, Vol. 11, Issue 4, pp. 2815-2819, (2016) (PubMed).
: "Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 196, Issue 4, pp. 1495-506, (2016) (PubMed).
: "Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients." dans: Oncotarget, Vol. 7, Issue 47, pp. 77237-77243, (2016) (PubMed).
: "Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis." dans: Tumour biology, (2014) (PubMed).
: "B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 8, pp. 4165-74, (2012) (PubMed).
: "Tissue-expressed B7x affects the immune response to and outcome of lethal pulmonary infection." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 6, pp. 3054-63, (2012) (PubMed).
: "Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation." dans: Blood, Vol. 118, Issue 9, pp. 2502-10, (2011) (PubMed).
: "B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Issue 49, pp. 19458-63, (2007) (PubMed).
: "Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 23, Issue 12, pp. 2934-2941, (2018) (PubMed).
: "Clinical relevance of expression of B7-H1 and B7-H4 in ovarian cancer." dans: Oncology letters, Vol. 11, Issue 4, pp. 2815-2819, (2016) (PubMed).
: "Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 196, Issue 4, pp. 1495-506, (2016) (PubMed).
: "Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients." dans: Oncotarget, Vol. 7, Issue 47, pp. 77237-77243, (2016) (PubMed).
: "Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis." dans: Tumour biology, (2014) (PubMed).
: "B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 8, pp. 4165-74, (2012) (PubMed).
: "Tissue-expressed B7x affects the immune response to and outcome of lethal pulmonary infection." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 6, pp. 3054-63, (2012) (PubMed).
: "Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation." dans: Blood, Vol. 118, Issue 9, pp. 2502-10, (2011) (PubMed).
: "B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Issue 49, pp. 19458-63, (2007) (PubMed).
Pseudonymes pour VTCN1 Anticorps
V set domain containing T cell activation inhibitor 1 L homeolog (vtcn1.L) AnticorpsV-set domain containing T cell activation inhibitor 1 (VTCN1) Anticorps
V-set domain containing T-cell activation inhibitor 1 (VTCN1) Anticorps
V set domain containing T cell activation inhibitor 1 (vtcn1) Anticorps
V-set domain containing T cell activation inhibitor 1 (Vtcn1) Anticorps
B7-H4 Anticorps
B7h.5 Anticorps
B7h4 Anticorps
B7H4 Anticorps
B7s1 Anticorps
B7S1 Anticorps
B7x Anticorps
B7X Anticorps
BC032925 Anticorps
PRO1291 Anticorps
RGD1311204 Anticorps
VCTN1 Anticorps
Avez-vous cherché autre chose?
- VTA1 Anticorps
- VSX1 Anticorps
- VSTM4 Anticorps
- VSTM2L Anticorps
- VSTM1 Anticorps
- VSNL1 Anticorps
- VSIG8 Anticorps
- VSIG4 Anticorps
- VSIG2 Anticorps
- VSIG1 Anticorps
- VRK3 Anticorps
- VRK2 Anticorps
- VRK1 Anticorps
- Vpx Protein Anticorps
- VPS72 Anticorps
- VPS54 Anticorps
- VPS53 Anticorps
- VPS52 Anticorps
- VPS51 Anticorps
- VPS4B Anticorps
- VTI1A Anticorps
- VTI1B Anticorps
- VWA1 Anticorps
- VWA2 Anticorps
- VWA5A Anticorps
- VWC2 Anticorps
- VWCE Anticorps
- VWF Anticorps
- WAP Four-Disulfide Core Domain 8 Anticorps
- WAP Four-Disulfide Core Domain 9 Anticorps
- WAPAL Anticorps
- WARS Anticorps
- WARS2 Anticorps
- WASF1 Anticorps
- WASF2 Anticorps
- WASF3 Anticorps
- WASP Anticorps
- WBP1 Anticorps
- WBP11 Anticorps
- WBP2 Anticorps
Vous êtes ici:
